(1)
Onsanit, S.; Wanichang, K.; Anutarapongpan, K. Cost-Effectiveness of Crystalline and Amorphous Atorvastatin in the Secondary Prevention of Cardiovascular Disease. SRIMEDJ 2019, 34, 219-225.